Minerva Neurosciences | NERV - EPS Earnings Per Share


Minerva Neurosciences reported $-0.56 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Adma Biologics USD 0.16 0.03 Jun/2026
ALKERMES USD 0.09 0.09 Sep/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
AstraZeneca USD 2.79 0.16 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Cipla INR 10.85 1.09 Sep/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.07 0.16 Jun/2026
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 7.48 0.9 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.7 0.2 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.87 0.1 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
Takeda JPY 116.95 45.3 Sep/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024